Feed 6185.HK
61
CanSino Biologics Inc.
6185.HK · HKSE
$24.58 -0.65% (-$0.16)
1M +5.73%
Market Cap ¥7.4B
P/E Ratio 273.92x
Div. Yield -
ROE 0.54%
Valuation
17 /100
Expensive EV/EBITDA 122.84x
P/S 7.21x
P/B 1.50x
Growth
16 /100
Declining Book val. growth 9.78%
Rev. growth 0.03%
FCF growth N/A
Profitability
25 /100
Weak Net margin 2.63%
Op. margin 10.96%
FCF margin 14.81%
Quality
3 /100
Poor ROE 0.54%
ROA 0.38%
Asset turnover 0.14x
Debt
77 /100
Low Current ratio 3.55x
Int. coverage -2.03x
Net debt/EBITDA 0.87x
Stability
19 /100
Unstable Rev. volatility 106.33%
EPS volatility 90.50%
Profitable years 1
Vprašajte StockBota o 6185.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Xue Feng Yu
Employees
1,134
Headquarters
Tianjin
Prihajajoči dogodki
29 AVG.
Earnings
Upcoming earnings report